Editorial · 2019
Conference abstract
Pharmaceutical nanocarriers: Past/present/future
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
About fifteen years ago, the National Institute of Health (USA) launched the National Nanotechnology Initiative to support, coordinate, and advance research and development of nanoscale projects. The impact of this new program on health-science related research and development became quickly visible. Broad governmental financial support advanced the start of new, and the deepening of already existing, interdisciplinary research. The anticipated merger of nanoscience with medicine quickly instigated the conceptualization of nanomedicine. The adoption of nanoscience terminology by pharmaceutical scientists resulted in the advent of nanopharmaceuticals. The term â??nanoâ?� became tantamount to â??cuttingedgeâ?� and was quickly embraced by the pharmaceutical science community. Colloidal drug delivery systems reemerged as nanodrug delivery systems; colloidal gold became a suspension of nano gold particles. In this presentation, I shall review nanoscience related definitions applied to pharmaceuticals, discuss currently approved drug formulations which are publicized as nanopharmaceuticals and briefly review the ongoing clinical trials within the broad field of nanomedicine. When confining the definition of nanopharmaceuticals to therapeutic formulations, in which the unique physicochemical properties expressed in the nanosize range, when man-made, play the pivotal therapeutic role, I shall argue that the current number of clincial trials neither reflects the massive investments made in the field of nanomedicine nor the general hype associated with the term â??nanoâ?�. However, I shall also emphasize the tremendous efforts currently underway worldwide, at the bench and in preclinical research, in order to make the big promise of the nano revolution a reality.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 7 Mar 2016
Pharmaceuticial Nanocarriers: Past / Present / Future
Commentary · 31 Oct 2024
The Comprehensive Guide to Agricultural Science: Past, Present and Future
Short communication · 21 Mar 2022
Herbal drugs : past, present and future scenario in India
Conference abstract · 31 Jul 2021
Antimicrobial Resistance, Past, Present, and Future Prospects
More from this journal
The newest in Pharmaceutica Analytica Acta.
Article · 16 Sep 2026
The Fc Domains in the Monoclonal Antibody and Fusion Protein Significantly Boost the Biocomposite Suspension's Power to Combat Harmful Microorganisms, Enhance Drug Delivery, and Improve Protein Stability
Article · 26 Jun 2026
Green Pathways in Drug Quality Assessment: The Growing Role of Sustainable Pharmaceutical Analytics
Article · 26 Jun 2026
Advanced Single-Cell Signal Analysis: The Role of Ghost Cytometry in Cell Therapy Characterization
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalPharmaceutica Analytica Acta
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Volkmar Weissig”

